Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72

Vaccines (Basel). 2020 Feb 20;8(1):94. doi: 10.3390/vaccines8010094.

Gustavo Cabral-Miranda^{1

2}, Stephanie M Lim³, Mona O Mohsen^{1

2}, Ilya V Pobelov⁴, Elisa S Roesti², Matthew D Heath⁵, Murray A Skinner⁵, Matthias F Kramer⁵, Byron E E Martina^{3

6}, Martin F Bachmann^{1

2}

¹ The Jenner Institute, Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), University of Oxford, Oxford OX1 2JD, UK.
² Immunology, RIA, Inselspital, University of Bern, 3010 Bern, Switzerland.
³ Artemis Bio-Support, Molengraaffsingel, 2629 Delft, The Netherlands.
⁴ Department of Chemistry and Biochemistry, University of Bern, 3010 Bern, Switzerland.
⁵ Bencard Adjuvant Systems, Worthing BN14 8SA, UK.
⁶ Department of Viroscience, Erasmus Medical Center, 3015 GD Rotterdam, The Netherlands.

Abstract

The authors wish to make the following correction to their paper [...].